Adaptimmune Therapeutics Plc ADR (ADAPY)

$0.05 0.00 (-1.82%)
Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 45,989,301
Avg Vol 115,232,406
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 15%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Adaptimmune Therapeutics plc engages in research, development, and subsequent manufacture and commercialisation of cell therapies to treat cancer in the United States and the United Kingdom. The company was founded in 2008 and is headquartered in Abingdon, the United Kingdom.

Industry: Biotechnology
Sector: Healthcare
Address:
The Innovation Centre, 99 Park Drive, Milton Park, Abingdon, United Kingdom
US_Bull
US_Bull Sep. 18 at 6:27 PM
$ADAPY ESMO is next month in Barcelona and checked the confirmed company list and Immunocore is listed.
0 · Reply
duepillagence
duepillagence Sep. 18 at 6:05 PM
$ADAPY The dates here corresponds around the "divestment" of PRAME... 👀
2 · Reply
Stockinvestor73
Stockinvestor73 Sep. 18 at 5:26 PM
$ADAPY i hear kenya calling my name....my bags are packed
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Sep. 18 at 5:02 PM
$ADAPY If you don’t have industry colleagues, contacts, or friends, including some who interviewed former adappies looking for jobs, it’s completely understandable that one would place 100% reliance on what google and chatlgbtq says about anything. Turnoff the computer and go out and talk to people in the industry. No one wants what’s left. Safety is a concern.
1 · Reply
Hodl707
Hodl707 Sep. 18 at 4:35 PM
$ADAPY
0 · Reply
Stockinvestor73
Stockinvestor73 Sep. 18 at 1:47 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:59 PM
$ADAPY Its time soon the 'Adaptimmune Assist' website is completely gone the Tecelra tech transfer is done completely in the hands of USW now.
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:57 PM
$ADAPY Immatics clearly makes the most sense as they are already heavily engaged with PRAME cell therapy technology and the linking cross-over Dejka and Sandra. Immunocore has more cash power and they are located right across of us in Abington, UK in our hood but they do soluble engagers and not cell therapy modality but still.
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:55 PM
$ADAPY i) USW; ii) Immunocore, iii) Immatics; iv) BP; v) Private equity which one is it.
2 · Reply
US_Bull
US_Bull Sep. 18 at 12:46 PM
$ADAPY Etc.
2 · Reply
Latest News on ADAPY
No data available.
US_Bull
US_Bull Sep. 18 at 6:27 PM
$ADAPY ESMO is next month in Barcelona and checked the confirmed company list and Immunocore is listed.
0 · Reply
duepillagence
duepillagence Sep. 18 at 6:05 PM
$ADAPY The dates here corresponds around the "divestment" of PRAME... 👀
2 · Reply
Stockinvestor73
Stockinvestor73 Sep. 18 at 5:26 PM
$ADAPY i hear kenya calling my name....my bags are packed
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Sep. 18 at 5:02 PM
$ADAPY If you don’t have industry colleagues, contacts, or friends, including some who interviewed former adappies looking for jobs, it’s completely understandable that one would place 100% reliance on what google and chatlgbtq says about anything. Turnoff the computer and go out and talk to people in the industry. No one wants what’s left. Safety is a concern.
1 · Reply
Hodl707
Hodl707 Sep. 18 at 4:35 PM
$ADAPY
0 · Reply
Stockinvestor73
Stockinvestor73 Sep. 18 at 1:47 PM
$ADAPY
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:59 PM
$ADAPY Its time soon the 'Adaptimmune Assist' website is completely gone the Tecelra tech transfer is done completely in the hands of USW now.
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:57 PM
$ADAPY Immatics clearly makes the most sense as they are already heavily engaged with PRAME cell therapy technology and the linking cross-over Dejka and Sandra. Immunocore has more cash power and they are located right across of us in Abington, UK in our hood but they do soluble engagers and not cell therapy modality but still.
0 · Reply
US_Bull
US_Bull Sep. 18 at 12:55 PM
$ADAPY i) USW; ii) Immunocore, iii) Immatics; iv) BP; v) Private equity which one is it.
2 · Reply
US_Bull
US_Bull Sep. 18 at 12:46 PM
$ADAPY Etc.
2 · Reply
PaidPiper
PaidPiper Sep. 18 at 12:00 PM
$ADAPY @duepillagence it's usually just a statement that says their intended operations for the upcoming year are lawful and any notable changes in ownership. Don't get too excited
1 · Reply
duepillagence
duepillagence Sep. 18 at 11:54 AM
$ADAPY The following mechanics typically apply to submission of statements of confirmation:
0 · Reply
PaidPiper
PaidPiper Sep. 18 at 11:47 AM
$ADAPY Adaps Q3 update from Nov 13th, 2024 said it would cease enrollment in SURPASS-3 as part of a restructuring that prioritized programs with the highest return on invested capital. It did NOT announce that SURPASS-3 was being stopped for a safety concern. This took me less than 2 minutes to find.
0 · Reply
PaidPiper
PaidPiper Sep. 18 at 11:43 AM
$ADAPY @Stonky LOL this is 100% wrong folks. It has no idea what it's talking about
0 · Reply
Stonky_Mcprofitface
Stonky_Mcprofitface Sep. 18 at 11:30 AM
$ADAPY SURPASS-3 was stopped for safety.
0 · Reply
PaidPiper
PaidPiper Sep. 17 at 10:46 PM
$ADAPY it is due tomorrow THROUGH TO October 2nd. It's a window not a hard cutoff
0 · Reply
HellasManN10
HellasManN10 Sep. 17 at 10:13 PM
$ADAPY It is extraordinarily interesting to be a week ahead; you can understand so many things.
1 · Reply
duepillagence
duepillagence Sep. 17 at 9:29 PM
$ADAPY PROC rights a key element. Speaking of, I find it interesting that the rights outlined on adapys website doesnt specify which category those rights fall under (autologus vs allogeneic) leaving it open ended implies we're holding rights to exercise options to either which adds more value for the buyer/partner to consider!!!
0 · Reply
PaidPiper
PaidPiper Sep. 17 at 9:20 PM
$ADAPY we have a statement of confirmation due tmro-Oct 2nd. That might give more insight into what they've been doing from May 30th to now. Either way, make money elsewhere while we wait. That's what I do
0 · Reply
PaidPiper
PaidPiper Sep. 17 at 8:50 PM
$ADAPY 5 weeks since PROC data was made available to Adap. Probably quielty sharing the data under confidentiality to potential suitors. They wouldn't necessarily be starting from zero on August 12; the new clinical info could simply be the piece needed to advance an existing process
0 · Reply
US_Bull
US_Bull Sep. 17 at 7:50 PM
$ADAPY You remember months ago there was that one week where volume was in the millions for several days and last few weeks volume is dead. You don't go from millions of volume OTC to know volume on the OTC without something happening behind the curtains. Things take time, Director's severance, the DD process in itself can take many months especially when you have many untangled ends like ADAP has with assets, tech's etc.
1 · Reply
US_Bull
US_Bull Sep. 17 at 5:11 PM
$ADAPY Actually no incorrect you were meant to say each day is manipulated as hell cause it follows the same procedure red at market open 9:30 on no shares and kept red all day until it is reversed but I don't really give a f cause I know I am getting paid. Bro you are too emotinally attached to a penny stock you know you are gonna get paid but who gives a flying f if it is tomorrow or in months. My advice stop being emotional when they manipulated it down to >30% in the red means abso fucking lutly nothing as I have been saying it is fluff. You survived actual brutality 5 times at 0.0001$ on the expert market the rest take it as being a piece of cake.
1 · Reply